ACTH, glucagon and gastrin production by a pancreatic islet cell carcinoma and its treatment.

PubWeight™: 1.08‹?› | Rank: Top 10%

🔗 View Article (PMID 4358344)

Published in Clin Endocrinol (Oxf) on October 01, 1973

Authors

P E Belchetz, C L Brown, H L Makin, D J Trafford, A S Mason, S R Bloom, J G Ratcliffe

Articles by these authors

Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature (1998) 7.36

Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab (2001) 6.41

A role for glucagon-like peptide-1 in the central regulation of feeding. Nature (1996) 6.03

Terminology in gynaecological cytopathology: report of the Working Party of the British Society for Clinical Cytology. J Clin Pathol (1986) 5.76

Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet (1987) 4.97

Experience with human growth hormone in Great Britain: the report of the MRC Working Party. Clin Endocrinol (Oxf) (1979) 4.42

The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology (2000) 3.80

Clinicopathologic features of BRCA-linked and sporadic ovarian cancer. JAMA (2000) 3.69

Ghrelin causes hyperphagia and obesity in rats. Diabetes (2001) 3.62

A glucagonoma syndrome. Lancet (1974) 3.56

Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology (1985) 3.36

A radioimmunoassay for rat plasma ACTH. Endocrinology (1971) 3.35

Vasoactive intestinal peptide and watery-diarrhoea syndrome. Lancet (1973) 3.22

Hypophysial responses to continuous and intermittent delivery of hypopthalamic gonadotropin-releasing hormone. Science (1978) 3.15

Possible dual role for vasoactive intestinal peptide as gastrointestinal hormone and neurotransmitter substance. Lancet (1976) 3.08

Distribution and release of human pancreatic polypeptide. Gut (1976) 3.02

Pathological and clinical findings in a series of 67 cases of medullary carcinoma of the thyroid. J Clin Pathol (1966) 2.99

Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology (2005) 2.80

Endocrine tumour in kidney affecting small bowel structure, motility, and absorptive function. Gut (1971) 2.75

Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone. Lancet (1974) 2.65

Neuron-specific enolase is produced by neuroendocrine tumours. Lancet (1981) 2.63

Breast vs bottle: endocrine responses are different with formula feeding. Lancet (1980) 2.52

Measurement of fasting and postprandial plasma VIP in man. Gut (1978) 2.48

Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. J Clin Invest (1999) 2.48

Nesidioblastosis of the pancreas: definition of the syndrome and the management of the severe neonatal hyperinsulinaemic hypoglycaemia. Arch Dis Child (1981) 2.36

Central and peripheral administration of kisspeptin-10 stimulates the hypothalamic-pituitary-gonadal axis. J Neuroendocrinol (2004) 2.27

Gut-hormone profile in coeliac disease. Lancet (1978) 2.25

Saturation of fat and cholecystokinin release: implications for pancreatic carcinogenesis. Lancet (1989) 2.25

Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers. Am J Physiol Endocrinol Metab (2001) 2.24

Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. J Immunol (2001) 2.20

Long-term treatment of acromegaly with bromocriptine. Br Med J (1977) 2.18

Role of assays for parathyroid-hormone-related protein in investigation of hypercalcaemia. Lancet (1992) 2.17

Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. J Clin Endocrinol Metab (1998) 2.17

Characterization of a gastrin releasing peptide from porcine non-antral gastric tissue. Biochem Biophys Res Commun (1979) 2.16

Gut hormones and appetite control. Gastroenterology (2007) 2.16

A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo. Endocrinology (1998) 2.14

Pancreatic polypeptide in insulinomas, gastrinomas, vipomas, and glucagonomas. Lancet (1976) 2.13

The ileal brake--inhibition of jejunal motility after ileal fat perfusion in man. Gut (1984) 2.11

Neuropeptide Y distribution in the rat brain. Science (1983) 2.10

Growth-hormone release-inhibiting hormone in gastrointestinal and pancreatic D cells. Lancet (1975) 2.04

The role of the sympathetic innervation in the control of plasma glucagon concentration in the calf. J Physiol (1973) 2.01

Advanced carcinoma of the prostate: treatment with a gonadotrophin releasing hormone agonist. Br Med J (Clin Res Ed) (1983) 1.93

Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety. Br J Surg (2006) 1.91

Avoidance of anencephalic and spina bifida births by maternal serum-alphafetoprotein screening. Lancet (1978) 1.90

Can I have an ambulance, doctor? Br Med J (1974) 1.90

Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39. Diabetes (1999) 1.90

Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice. J Clin Invest (1997) 1.89

Calcitonin gene-related peptide immunoreactivity in the spinal cord of man and of eight other species. J Neurosci (1984) 1.88

Urine screening for leucocytes and bacteria by dipstick and reflectance spectrophotometry. Med Lab Sci (1989) 1.87

Suicidal insulin overdose managed by excision of insulin injection site. Br Med J (Clin Res Ed) (1982) 1.86

Effects of stimulation of the chorda tympani in bursts on submaxillary responses in the cat. J Physiol (1982) 1.84

Suppression of pancreatic endocrine tumour secretion by long-acting somatostatin analogue. Lancet (1979) 1.81

Development of neuroendocrine tumors in the gastrointestinal tract of transgenic mice. Heterogeneity of hormone expression. Am J Pathol (1990) 1.80

Thyroid function in adults with Down's syndrome. J Clin Endocrinol Metab (1977) 1.78

Modifying the request behaviour of clinicians. J Clin Pathol (1992) 1.78

Enkephalin-like immunoreactivity in the human gastrointestinal tract. Lancet (1977) 1.75

Increased leptin levels in serum and peritoneal fluid of patients with pelvic endometriosis. J Clin Endocrinol Metab (2000) 1.75

Melanin-concentrating hormone acutely stimulates feeding, but chronic administration has no effect on body weight. Endocrinology (1997) 1.74

The effect of truncal and selective vagotomy on the release of pancreatic glucagon, insulin and enteroglucagon. Br J Surg (1974) 1.73

Bombesin-like immunoreactivity in the lung. Nature (1978) 1.73

Impaired action of thyroid hormone associated with smoking in women with hypothyroidism. N Engl J Med (1995) 1.73

Idiopathic hypopituitarism in the elderly. Br Med J (Clin Res Ed) (1985) 1.72

Localization of insulinomas by selective intraarterial calcium injection. J Clin Endocrinol Metab (1996) 1.72

Current views on cervical intraepithelial neoplasia. J Clin Pathol (1991) 1.72

Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients. Lancet (1974) 1.71

Pancreatic polypeptide reduces appetite and food intake in humans. J Clin Endocrinol Metab (2003) 1.71

Abnormalities of vasoactive intestinal polypeptide-containing nerves in Crohn's disease. Gastroenterology (1980) 1.70

Bromocriptine treatment of acromegaly. Br Med J (1975) 1.70

An enteroglucagon tumour. Gut (1972) 1.69

Mechanism of pancreatic polypeptide release in man. Lancet (1977) 1.68

Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers. Gut (1987) 1.68

Leucocyte esterase-nitrite screening method for pyuria and bacteriuria. J Clin Pathol (1985) 1.67

Motilin and the interdigestive migrating motor complex in man. Dig Dis Sci (1979) 1.67

A radioimmunoassay for neurotensin in human plasma. J Endocrinol (1979) 1.66

Neuropeptide Y distribution in human brain. Nature (1984) 1.66

Glucagon-like peptide-1 is a physiological incretin in rat. J Clin Invest (1995) 1.66

Repeated intracerebroventricular administration of glucagon-like peptide-1-(7-36) amide or exendin-(9-39) alters body weight in the rat. Endocrinology (1999) 1.65

Bombesin: action on gut hormones and calcium in man. J Clin Endocrinol Metab (1982) 1.65

Food fails to suppress ghrelin levels in obese humans. J Clin Endocrinol Metab (2002) 1.65

Epidemiological and clinical picture of Addison's disease. Lancet (1968) 1.63

Changing trends in the management of phaeochromocytoma. Br J Surg (1998) 1.62

Vasoactive intestinal peptide in relation to atropine resistant vasodilatation in the submaxillary gland of the cat. J Physiol (1980) 1.62

Ghrelin increases food intake in obese as well as lean subjects. Int J Obes (Lond) (2005) 1.62

Management of women with abnormal cervical smears: supplement to terminology in gynaecological cytopathology. J Clin Pathol (1987) 1.61

Oncogenous osteomalacia and malignancy. Clin Endocrinol (Oxf) (1992) 1.61

Gastrointestinal hormones in short bowel syndrome. Peptide YY may be the 'colonic brake' to gastric emptying. Gut (1996) 1.60

Recognition site directing vitamin K-dependent gamma-carboxylation resides on the propeptide of factor IX. Cell (1987) 1.60

Origins of the sex difference in human urinary free cortisol excretion. Ann Clin Biochem (1996) 1.58

Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia (1990) 1.58

The role of the autonomic innervation in the control of glucagon release during hypoglycaemia in the calf. J Physiol (1974) 1.58

The arms of the college. J R Coll Physicians Lond (1992) 1.57

Ectopic hormone production by non-endocrine tumours. Clin Endocrinol (Oxf) (1974) 1.56

Effect of neurotensin on gastric function in man. Lancet (1980) 1.55

Frequency and amplitude of gonadotropin-releasing hormone stimulation and gonadotropin secretion in the rhesus monkey. Endocrinology (1981) 1.55

Effect of educational feedback on clinicians' requesting of cardiac enzymes. Ann Clin Biochem (1992) 1.55

Calcitonin gene-related peptide in cardiovascular tissues of the rat. Neuroscience (1985) 1.55

Consistency of histopathological reporting of breast lesions detected by screening: findings of the U.K. National External Quality Assessment (EQA) Scheme. U. K. National Coordinating Group for Breast Screening Pathology. Eur J Cancer (1994) 1.54

Lung tumours and ACTH production. Clin Endocrinol (Oxf) (1977) 1.54

Semi-automated radioimmunoassays for total serum thyroxine and triiodothyronine. Clin Chim Acta (1975) 1.53